Bullish
SLS Stock Jumps Overnight: CEO Doubles Down On ‘Steadfast’ Confidence In AML Drug And Pushes For 20M Share Plan Approval
Sellas Life Sciences Group (SLS) stock rose over 7% after its CEO reiterated strong confidence in the company's lead AML therapy, GPS, currently in a ...